IMR Press / FBL / Volume 8 / Issue 6 / DOI: 10.2741/881

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Acute cholangitis
Show Less
1 Departments of Surgery, Anesthesiology and Critical Care Medicine, Johns Hopkins University Schools of Medicine and Nursing, 600 N. Wolfe Street, Blalock 685, Baltimore, MD
2 Department of Surgery, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, WI

Academic Editor: Mohammad Abedin

Front. Biosci. (Landmark Ed) 2003, 8(6), 1229–1239;
Published: 1 September 2003
(This article belongs to the Special Issue Molecular basis of gallstone pathogenesis)

Acute cholangitis is an infectious disease of the biliary tract with a wide spectrum of presentation ranging in severity from a mild form with fever and jaundice, to a severe form with septic shock. Supportive care with hydration, antibiotics, and biliary decompression remain the cornerstones of care. Broad-spectrum antibiotics should include coverage of E.coli, Klebsiella sp., Enterococcus sp., and in severely critically ill patients, coverage of additional pathogens such as Bacteriodes sp., Pseudomonas, and yeast should be considered. Biliary decompression should be performed early in the course of the illness when the patient has not improved or if they worsen with hydration and antibiotics. Stable patients should have biliary decompression usually within 72 hours when the fever has resolved. Urgent decompression with a percutaneous or endoscopic stent is preferred over an operative decompression in most institutions. Outcome is dependent on the etiology of the obstruction (benign versus malignant) and the ability to achieve biliary decompression.

Back to top